Literature DB >> 34103714

SARS-CoV-2 takes its Toll.

Alan Sariol1, Stanley Perlman2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34103714      PMCID: PMC8238877          DOI: 10.1038/s41590-021-00962-w

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


× No keyword cloud information.
  2 in total

1.  Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection.

Authors:  Haixia Zhou; Jincun Zhao; Stanley Perlman
Journal:  MBio       Date:  2010-10-19       Impact factor: 7.867

2.  TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.

Authors:  Min Zheng; Rajendra Karki; Evan Peter Williams; Dong Yang; Elizabeth Fitzpatrick; Peter Vogel; Colleen Beth Jonsson; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2021-05-07       Impact factor: 25.606

  2 in total
  13 in total

Review 1.  SARS-CoV-2 pathogenesis.

Authors:  Mart M Lamers; Bart L Haagmans
Journal:  Nat Rev Microbiol       Date:  2022-03-30       Impact factor: 60.633

Review 2.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 3.  Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019.

Authors:  Jiayu Dai; Yibo Wang; Hongrui Wang; Ziyuan Gao; Ying Wang; Mingli Fang; Shuyou Shi; Peng Zhang; Hua Wang; Yingying Su; Ming Yang
Journal:  Front Microbiol       Date:  2022-06-27       Impact factor: 6.064

4.  Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.

Authors:  Mizanur Rahman; Martin Irmler; Sandeep Keshavan; Micol Introna; Johannes Beckers; Lena Palmberg; Gunnar Johanson; Koustav Ganguly; Swapna Upadhyay
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

Review 5.  Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?

Authors:  Theoharis C Theoharides
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.682

Review 6.  An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants.

Authors:  Mohammad Enamul Hoque Kayesh; Michinori Kohara; Kyoko Tsukiyama-Kohara
Journal:  Viruses       Date:  2021-11-18       Impact factor: 5.048

Review 7.  Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection.

Authors:  Hi Eun Jung; Heung Kyu Lee
Journal:  Viruses       Date:  2021-10-22       Impact factor: 5.048

8.  The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.

Authors:  Rafael Moreno-Luna; Mª Carmen Durán-Ruiz; Lucía Beltrán-Camacho; Sara Eslava-Alcón; Marta Rojas-Torres; Daniel Sánchez-Morillo; Mª Pilar Martinez-Nicolás; Victoria Martín-Bermejo; Inés García de la Torre; Esther Berrocoso; Juan Antonio Moreno
Journal:  Mol Med       Date:  2022-04-09       Impact factor: 6.354

Review 9.  Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.

Authors:  Laure-Alix Clerbaux; Maria Cristina Albertini; Núria Amigó; Anna Beronius; Gillina F G Bezemer; Sandra Coecke; Evangelos P Daskalopoulos; Giusy Del Giudice; Dario Greco; Lucia Grenga; Alberto Mantovani; Amalia Muñoz; Elma Omeragic; Nikolaos Parissis; Mauro Petrillo; Laura A Saarimäki; Helena Soares; Kristie Sullivan; Brigitte Landesmann
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

Review 10.  Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey.

Authors:  Estefanía Calvo-Alvarez; Maria Dolci; Federica Perego; Lucia Signorini; Silvia Parapini; Sarah D'Alessandro; Luca Denti; Nicoletta Basilico; Donatella Taramelli; Pasquale Ferrante; Serena Delbue
Journal:  Microorganisms       Date:  2022-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.